47 results
Page 2 of 3
424B3
zvmjl 9ziebr0
19 Aug 21
Prospectus supplement
9:05pm
8-K/A
1be2wgxmkj
16 Aug 21
Completion of Acquisition or Disposition of Assets
5:23pm
424B3
khjib5p0m3izjtdx
12 Aug 21
Prospectus supplement
4:21pm
8-K
pn0xg1s
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
425
7ggi5p2wpv7
7 Jul 21
Business combination disclosure
4:11pm
424B3
jl3a5ri
25 Jun 21
Prospectus supplement
12:48pm
425
qt3o138i286ds
15 Jun 21
Business combination disclosure
12:00am
425
xtci0pu0e vb248r5gy
14 May 21
Business combination disclosure
4:06pm
S-4/A
EX-10.34
f7ywv0m
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
1ktjpuj9fenzi9 1s
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4
erl221ppf
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
8-K
EX-2.1
vfyt7e3v9so
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-2.1
390vde8e
8 Jan 21
Business combination disclosure
7:02am
10-K
54bmsw5tj9nzedcvaqxa
24 Mar 20
Annual report
12:00am
8-K
EX-1.1
luwj nxlq3i75j654
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm